These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36762791)

  • 41. Malignant transformation arising from mature ovarian cystic teratoma: A case series.
    Qin L; Zhao T; Liu X; Wang H; Gu X; Chen D; Wang Z; He D
    Medicine (Baltimore); 2021 Apr; 100(13):e24726. PubMed ID: 33787574
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Squamous cell carcinoma arising in an ovarian mature cystic teratoma complicating pregnancy: a case report.
    Mekaru K; Kamiyama S; Masamoto H; Yagi C; Hirakawa M; Inamine M; Nagai Y; Sakumoto K; Aoki Y
    Arch Gynecol Obstet; 2008 Sep; 278(3):287-90. PubMed ID: 18239927
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Squamous cell carcinoma in situ arising in ovarian mature cystic teratoma].
    Gurrera A; Brancato F; Puzzo L; Magro G; Greco P
    Pathologica; 2008 Feb; 100(1):9-12. PubMed ID: 18686519
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Squamous cell carcinoma arising within a mature cystic teratoma with invasion into the adjacent small intestine: a case report.
    Song W; Conner M
    Int J Gynecol Pathol; 2012 May; 31(3):272-5. PubMed ID: 22498945
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Large cell neuroendocrine carcinoma arising in mature cystic teratoma: a case report and review of the literature.
    Miyamoto M; Takano M; Goto T; Kato M; Sasaki N; Furuya K
    Eur J Gynaecol Oncol; 2012; 33(4):414-8. PubMed ID: 23091901
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The evolution of mature cystic teratomas of the ovary into squamous cell carcinoma: two case reports and review of the literature.
    Ziadeh H; Duforestel T; Bouredji K; Re D; Debono L; Zreik T; Moufawad G; Ghaname W
    J Obstet Gynaecol; 2022 Jul; 42(5):838-841. PubMed ID: 35225134
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Can malignant transformation in mature cystic teratoma be preoperatively predicted?
    Futagami M; Yokoyama Y; Mizukami H; Shigeto T; Mizunuma H
    Eur J Gynaecol Oncol; 2012; 33(6):662-5. PubMed ID: 23327068
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Successful treatment of advanced squamous cell carcinoma arising from mature cystic teratoma of the ovary with homologous recombination deficiency: A case report.
    Tamura R; Yamaguchi M; Kitani Y; Nishikawa N; Kawasaki T; Kikuchi A
    Int J Surg Case Rep; 2023 Jun; 107():108329. PubMed ID: 37216734
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A rare case of squamous cell carcinoma
    Kyeong HK; Ku HR; Kim CW; Heo EJ
    Obstet Gynecol Sci; 2018 Sep; 61(5):631-635. PubMed ID: 30255001
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical analysis of 44 cases with malignant transformation of ovarian mature cystic teratoma].
    An JS; Wu LY; Li XG; Zhang R; Song Y; Ma SK; Liu LY; Hong WJ
    Zhonghua Fu Chan Ke Za Zhi; 2013 Feb; 48(2):123-8. PubMed ID: 23544494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mismatch repair deficiency is implicated in carcinoma arising from ovarian teratoma.
    Cheung AH; Chow C; Yu MY; Law WW; Law PP; Choi PC; Kang W; To KF
    Pathology; 2019 Jan; 51(1):67-73. PubMed ID: 30502217
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MR diagnosis of SCC arising within ovarian cystic teratomas: analysis of mural nodule characteristics.
    Fukuzawa T; Ohya A; Tanaka M; Shimizu M; Kobayashi K; Matsushita T; Watanabe T; Kobara H; Fujinaga Y
    Abdom Radiol (NY); 2024 Apr; 49(4):1264-1274. PubMed ID: 38393356
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined microcystic adnexal carcinoma and squamous cell carcinoma arising in the ovarian cystic teratoma--a brief case report.
    Yoon HK; Park SM; Joo JE
    J Korean Med Sci; 1994 Oct; 9(5):432-5. PubMed ID: 7702793
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Malignant transformation arising from mature cystic teratoma of the ovary: a retrospective study of 20 cases.
    Sakuma M; Otsuki T; Yoshinaga K; Utsunomiya H; Nagase S; Takano T; Niikura H; Ito K; Otomo K; Tase T; Watanabe Y; Yaegashi N
    Int J Gynecol Cancer; 2010 Jul; 20(5):766-71. PubMed ID: 20973266
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characteristics and treatment outcomes of patients with malignant transformation arising from mature cystic teratoma of the ovary: experience at a single institution.
    Oranratanaphan S; Khemapech N
    Asian Pac J Cancer Prev; 2013; 14(8):4693-7. PubMed ID: 24083728
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic Alterations in Esophageal Tissues From Squamous Dysplasia to Carcinoma.
    Liu X; Zhang M; Ying S; Zhang C; Lin R; Zheng J; Zhang G; Tian D; Guo Y; Du C; Chen Y; Chen S; Su X; Ji J; Deng W; Li X; Qiu S; Yan R; Xu Z; Wang Y; Guo Y; Cui J; Zhuang S; Yu H; Zheng Q; Marom M; Sheng S; Zhang G; Hu S; Li R; Su M
    Gastroenterology; 2017 Jul; 153(1):166-177. PubMed ID: 28365443
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Malignant transformation rate and p53, and p16 expression in teratomatous skin of ovarian mature cystic teratoma.
    Zhu HL; Zou ZN; Lin PX; Li WX; Huang YE; Shi XX; Shen H
    Asian Pac J Cancer Prev; 2015; 16(3):1165-8. PubMed ID: 25735349
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Squamous cell carcinoma arising from mature cystic teratoma of the ovary: a clinicopathologic analysis.
    Kikkawa F; Ishikawa H; Tamakoshi K; Nawa A; Suganuma N; Tomoda Y
    Obstet Gynecol; 1997 Jun; 89(6):1017-22. PubMed ID: 9170484
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ovarian squamous cell carcinoma arising from mature cystic teratoma.
    Parithivel K; Jagannathan JP; Krajewski K; O'Regan K; Quick CM; Ramaiya N; Campos S
    Cancer Imaging; 2011 Jun; 11(1):67-9. PubMed ID: 21684828
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Squamous cell carcinoma arising from a mature cystic teratoma of the ovary: Successful treatment with carboplatin, paclitaxel, and bevacizumab.
    Fukase M; Ohta T; Watanabe N; Suzuki Y; Seino M; Sudo T; Nagase S
    Gynecol Oncol Rep; 2020 Nov; 34():100632. PubMed ID: 32964091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.